Search for: "SANOFI-AVENTIS V SANDOZ INC"
Results 1 - 20
of 41
Sorted by Relevance
|
Sort by Date
26 Dec 2010, 9:59 pm
By Donald Zuhn -- Last week, in Sanofi-Aventis v. [read post]
10 Sep 2009, 9:59 pm
The case, Sanofi-Aventis U.S. [read post]
17 Jun 2007, 7:53 pm
Sanofi-Aventis U.S. [read post]
2 Apr 2011, 11:58 pm
Sanofi-Aventis U.S. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/21: Aventis Pharama S.A., Sanofi-Aventis US LLC v. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
29 Jun 2018, 7:50 am
Thus, as in both Qualcomm and Rambus, Inc. v. [read post]
26 Aug 2010, 10:01 am
District Court for the District of Columbia’s 1997 decision in Bracco Diagnostics, Inc. v. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General… [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
7 Feb 2012, 2:25 pm
’s (“Sandoz’s”) ANDA No. 077857 for a generic version of Sanofi-aventis U.S. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
5 May 2010, 4:46 am
(Patent Docs) Plavix (Clopidogrel) – Netherlands: District Court of The Hague finds Sanofi-Aventis’ patent invalid for lack of inventive step in proceedings brought by RatioPharm (EPLAW) Rapamune (Sirolimus) – US: Patent infringement complaint following Paragraph IV certification: Pfizer Inc. et al. v. [read post]
15 Apr 2021, 10:51 am
Sanofi-Aventis U.S. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes… [read post]
7 Apr 2010, 4:30 am
– FDA’s approval letter for Orchid’s ANDA for generic Clarinex sets new 180-day exclusivity forfeiture (FDA Law Blog) Cozaar (Losartan) / Hyzaar (Hydrochlorothiazide, Losartan) – US: Rarely used exception to the first permitted commercial marketing/use PTE criterion (FDA Law Blog) Cozaar (Losartan) / Hyzaar (Hydrochlorothiazide, Losartan) – US: Generic Cozaar/Hyzaar 180-day exclusivity – Teva wins, FDA too (despite itself) in the Columbia District Court (FDA Law… [read post]
10 Jun 2010, 3:58 am
Kappos (Patent Docs) Products Allegra (Fexofenadine) - US: Patent infringement complaint following a Paragraph IV certification: Sanofi-Aventis U.S. [read post]
